Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells

Cell Death and Differentiation

Volumn 7, Issue 6, 2000, Pages 548-555

  Ramirez, C D ^a   Sleiman, R J ^a   Catchpoole, D R ^a,b   Stewart, B W ^b,c  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Eastern Sydney Area Health Service   (Australia)

Author keywords

Apoptosis; Differentiation; Leukaemia

Indexed keywords

CD3 ANTIGEN; DNA; ETOPOSIDE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL STRUCTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0034024422     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400686     Document Type: Article

References (47)

1. Calabretta B and Skorski T (1997) Gene regulatory mechanisms operative on haematopoietic cells: proliferation, differentiation and neoplasia. Crit. Rev. Euk. Gene Express. 7: 117-124
2. Greaves M (1998) Molecular genetics, natural history and the demise of childhood leukaemia. Eur. J. Cancer 35: 173-185
3. Stewart BW (1997) Induced apoptosis as the basis for cancer chemotherapy. Comm. Toxic 5: 541-553
4. Brown JM and Wouters BG (1999) Apoptosis, p53 and tumor cell sensitivity to anticancer agents. Cancer Res. 59: 1391-1399
5. Yung BYM, Luo KJ and Hui EKW (1992) Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60. Cancer Res. 52: 3593-3597
6. Warrell RP (1997) Differentiating agents. In: Cancer: principles and practice of oncology, De Vita VT, Hellman S, Rosenberg SA eds (Philadelphia: Lippincott-Raven) pp. 438-490
7. Perez C, Vilaboa NE, Garcia-Bermejo L, de Blas E, Creighton AM and Aller P (1997) Differentiation of U-937 promonocytic cells by etoposide and ICRF-193, two antitumour DNA topoisomerase II inhibitors with different mechanisms of action. J. Cell. Sci. 110: 337-343
8. Constantinou A, Grdina D, Kiguchi K and Huberman E (1992) The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression ion human K0562 leukemia cells. Exp. Cell Res. 203: 100-106
9. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T (1994) P53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810
10. Shaulsky G, Goldfinger N, Peled A and Rotter V (1991) Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88: 8982-8986
11. Zhang W, Hu G, Estey E, Hester J and Deisseroth A (1992) Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 7: 1645-1647
12. Jehn BM and Osborne BA (1997) Gene regulation associated with apoptosis. Crit. Rev. Euk Gene Express. 7: 179-193
13. Solary E, Bertrand R and Pommier Y (1994) Apoptosis of human leukaemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia 8: 792-797
14. Vangsted A, Neisig A, Wallin H, Zeuthen J and Geisler C (1993) Induction of CD3 delta epsilon omega by phorbol 12-myristate 13-acetate. Eur. J. Immunol. 23(6): 1351-1357
15. Catchpoole DR and Stewart BW (1993) Etoposide-induced cytotoxicity in two human T-cell leukaemic cell lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res. 53: 4287-4296
16. 2/M arrest: Higher order DNA fragmentation as an indicator of mechanism. Br. J. Cancer 77: 40-50
17. Ma DDF, Sylwestrowicz T, Janossy G and Hoffbrand AV (1983) The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation. Immunol. Today 4: 65-68
18. Clevers H, Alarcon B, Wileman T and Terhorst C (1988) The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6: 629-647
19. Martin SJ, Reutelingsperger C, McGahon A, Rader JA, van Schie CAA, LaFace DM and Green DR (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 or Abl. J. Exp. Med. 182: 1545-1556
20. Cohen GM, Sun XM, Fearnhead H, MacFarlane M, Brown DG, Snowden RTand Dinsdale D (1994) Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153: 507-516
21. Madrid-Marina V, Martinez-Valdez H and Cohen A (1990) Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukaemic cell lines. Cancer Res. 50: 2891-2894
22. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M (1993) Apoptotic death in epithelial cells: Cleavage of DNA to 300 and or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12: 3679-3684
23. Desjardins LM and MacManus JP (1995) An adherent cell model to study different stages of apoptosis. Exp. Cell Res. 216: 380-387
24. Lynch RG (1995) Differentiation and cancer: The conditional autonomy of phenotype Proc. Natl. Acad. Sci. USA 92: 647-648
25. Rappa G, Lorico A and Sartorelli AC (1990) Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II. Cancer Res. 50: 6723-6730
26. Nakaya K, Chou S, Kaneko M and Nakamura Y (1991) Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells. Jpn. J. Cancer Res. 82: 184-191
27. Constantinou A, Henning-Chubb C and Huberman E (1989) Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity. Cancer Res. 49: 1110-1117
28. Zwelling LA, Hinds M, Chan D, Altschuler E, Mayes J and Zipf TF (1990) Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocyte differentiation. Cancer Res. 50: 7116-7122
29. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metast. Rev. 11: 121-139
30. Darzynkiewicz Z (1995) Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J. Cell Biochem. 58: 151-159
31. Kerr JFR and Harmon BV (1991) Definition and incidence of apoptosis: An historical perspective. In: Apoptosis: The Molecular Basis of Cell Death, Tomei LD, Cope FD eds (New York: Cold Spring Harbor Laboratory Press) pp. 5-29
32. Bortner CD, Oldenburg NBE and Cidlowski JA (1995) The role of DNA fragmentation in apoptosis. T. Cell Biol. 5: 21-26
33. Pandey S, Walker PR and Sikorska M (1997) Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem. Cell Biol. 72: 625-629
34. Davies SL, Bergh J, Harris AL and Hickson ID (1997) Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors. Br. J. Cancer 75: 816-821
35. Sun X-M, Snowden RT, Dinsdale D, Ormerod MG and Cohen GM (1994) Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem. Pharmacol. 47: 187-195
36. Dini L, Coppola S, Ruzittu MT and Ghibelli L (1996) Multip e pathways for apoptotic nuclear fragmentation. Exp. Cell Res. 223: 340-347
37. Kikkawa U, Kishimoto A and Nishizuka Y (1989) The Protein Kinase C family: heterogeneity and its implications. Ann. Rev. Biochem. 58: 31-44
38. McConkey DJ, Hartzell P, Jondal M and Orrenius S (1989) Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264: 13399-13402
39. Lotem J, Cragoe EJ and Sachs L (1991 ) Rescue from programmed cell death in leukemia and normal cells. Blood 78: 953-960
40. Solary E, Bertrand R, Kohn KW and Pommier Y (1993) Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81: 1359-1368
41. 2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142: 4085-4092
42. Kizaki H, Tadakuma T, Odaka C, Muramatsu J and Ishimura Y (1998) Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. J. Immunol. 143: 1790-1794
43. Nathan I, Ben-Valid I, Henzel R, Masalha H, Baram SN, Dvilansky A and Parola AH (1998) Alterations in membrane lipid dynamics of leukaemic cells undergoing growth arrest and differentiation: dependency on the inducing agent. Exp. Cell Res. 239: 442-446
44. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA and Akbar AN (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24: 892-899
45. s induces differentiation and sensitized chronic myelogenous leukaemia-blast crisis K562 cells to 1-b-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Cell Growth Differ. 7: 1617-1623
46. Guchelaar H-J, Timmer-Bosscha H, Dam-Meiring A, Uges DRA Oosterhuis JW, de Vries EGE and Mulder NIH3T3 (1994) Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced differentiation of a murine embryonal carcinoma cell line. Int. J. Cancer 55: 442-447
47. Isonishi S, Hom DK, Eastman A and Howell SB (1994) Enhancement of sensitivity to platinum(II)-containing drugs by 12-0-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line. Br. J. Cancer 69: 217-221